Michael Y. Choi, MD

Morphic Therapeutic

Poster(s):

• E0359 - Full Target Engagement With Saturation of α4β7 Integrin Receptor Occupancy Resulting in Changes in Subset of Lymphocytes by MORF-057 Following 200 Mg Single and Twice Daily Dosing in Healthy Subjects
  Tuesday, October 25, 2022

  3:00 PM – 5:00 PM ET